Tolerance associated gene expression following allogeneic hematopoietic cell transplantation

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Pidala, Joseph ^a   Bloom, Gregory C ^a   Eschrich, Steven ^a   Sarwal, Minnie ^b   Enkemann, Steve ^a   Betts, Brian C ^a   Beato, Francisca ^a   Yoder, Sean ^a   Anasetti, Claudio ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD56 ANTIGEN; CD66 ANTIGEN; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL CYCLE; CELL LINEAGE; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MALE; MIDDLE AGED; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PATIENT CODING; ADVERSE EFFECTS; ALLOTRANSPLANTATION; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; PHENOTYPE;

ADULT; CASE-CONTROL STUDIES; CELL LINEAGE; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; MALE; MIDDLE AGED; PHENOTYPE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84925264706     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117001     Document Type: Article

References (47)

1. Bluestone JA (2011) Mechanisms of tolerance. Immunol Rev 241: 5-19. doi: 10.1111/j.1600-065X. 2011.01019.x PMID: 21488886
2. Brouard S, Mansfield E, Braud C, Li L, Giral M, et al. (2007) Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A 104: 15448-15453. PMID: 17873064
3. Braud C, Baeten D, Giral M, Pallier A, Ashton-Chess J, et al. (2008) Immunosuppressive drug-free operational immune tolerance in human kidney transplant recipients: Part I. Blood gene expression statistical analysis. J Cell Biochem 103: 1681-1692. PMID: 17910029
4. Kawasaki M, Iwasaki M, Koshiba T, Fujino M, Hara Y, et al. (2007) Gene expression profile analysis of the peripheral blood mononuclear cells from tolerant living-donor liver transplant recipients. Int Surg 92: 276-286. PMID: 18399100
5. Martinez-Llordella M, Lozano JJ, Puig-Pey I, Orlando G, Tisone G, et al. (2008) Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 118: 2845-2857. doi: 10.1172/JCI35342 PMID: 18654667
6. Stewart BL, Storer B, Storek J, Deeg HJ, Storb R, et al. (2004) Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 104: 3501-3506. PMID: 15292060
7. Pidala J, Lee SJ, Quinn G, Jim H, Kim J, et al. Variation in management of immune suppression after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 17: 1528-1536. doi: 10. 1016/j.bbmt.2011.03.006 PMID: 21440079
8. Filipovich AH,Weisdorf D, Pavletic S, Socie G, Wingard JR, et al. (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11: 945-956. PMID: 16338616
9. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, et al. (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15: 825-828. PMID: 7581076
10. Van Gelder RN, von Zastrow ME, Yool A, Dement WC, Barchas JD, et al. (1990) Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci U S A 87: 1663-1667. PMID: 1689846
11. Dobbin KK, Beer DG, Meyerson M, Yeatman TJ, Gerald WL, et al. (2005) Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clin Cancer Res 11: 565-572. PMID: 15701842
12. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264. PMID: 12925520
13. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15. PMID: 12582260
14. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193. PMID: 12538238
15. Tibshirani R (2006) A simple method for assessing sample sizes in microarray experiments. BMC Bioinformatics 7: 106. PMID: 16512900
16. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121. PMID: 11309499
17. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550. PMID: 16199517
18. Watkins NA, Gusnanto A, de Bono B, De S, Miranda-Saavedra D, et al. (2009) A HaemAtlas: characterizing gene expression in differentiated human blood cells. Blood 113: e1-9. doi: 10.1182/blood-2008-06-162958 PMID: 19228925
19. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, et al. (2008) Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 26: 317-325. doi: 10.1038/nbt1385 PMID: 18278033
20. Kohrt HE, Tian L, Li L, Alizadeh AA, Hsieh S, et al. (2013) Identification of gene microarray expression profiles in patients with chronic graft-versus-host disease following allogeneic hematopoietic cell transplantation. Clin Immunol 148: 124-135. doi: 10.1016/j.clim.2013.04.013 PMID: 23685278
21. Brown D, Trowsdale J, Allen R (2004) The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64: 215-225. PMID: 15304001
22. Kochi Y, Myouzen K, Yamada R, Suzuki A, Kurosaki T, et al. (2009) FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J Immunol 183: 5502-5510. doi: 10.4049/jimmunol.0901982 PMID: 19843936
23. Nagata S, Ise T, Pastan I (2009) Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells. J Immunol 182: 7518-7526. doi: 10.4049/jimmunol.0802230 PMID: 19494275
24. Goldstein DR, Tesar BM, Akira S, Lakkis FG (2003) Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 111: 1571-1578. PMID: 12750407
25. Porrett PM, Yuan X, LaRosa DF, Walsh PT, Yang J, et al. (2008) Mechanisms underlying blockade of allograft acceptance by TLR ligands. J Immunol 181: 1692-1699. PMID: 18641305
26. Zhao Y, Liu Q, Yang L, He D, Wang L, et al. (2013) TLR4 inactivation protects from graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Cell Mol Immunol 10: 165-175. doi: 10.1038/cmi.2012.58 PMID: 23262974
27. Aliahmad P, Kaye J (2008) Development of all CD4 T lineages requires nuclear factor TOX. J Exp Med 205: 245-256. doi: 10.1084/jem.20071944 PMID: 18195075
28. Workman CJ, Vignali DA (2005) Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223). J Immunol 174: 688-695. PMID: 15634887
29. Okamura T, Fujio K, Shibuya M, Sumitomo S, Shoda H, et al. (2009) CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2. Proc Natl Acad Sci U S A 106: 13974-13979. doi: 10. 1073/pnas.0906872106 PMID: 19666526
30. Bettini M, Szymczak-Workman AL, Forbes K, Castellaw AH, Selby M, et al. (2011) Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3. J Immunol 187: 3493-3498. doi: 10.4049/ jimmunol.1100714 PMID: 21873518
31. Jackson SH, Yu CR, Mahdi RM, Ebong S, Egwuagu CE (2004) Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling. J Immunol 172: 2307-2315. PMID: 14764699
32. Shi Y, Feng Y, Kang J, Liu C, Li Z, et al. (2007) Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. Nat Immunol 8: 817-824. PMID: 17618287
33. Hu Z, Huang Y, Liu Y, Sun Y, Zhou Y, et al. (2011) beta-Arrestin 1 modulates functions of autoimmune T cells from primary biliary cirrhosis patients. J Clin Immunol 31: 346-355. doi: 10.1007/s10875-010-9492-4 PMID: 21243522
34. Lesley R, Xu Y, Kalled SL, Hess DM, Schwab SR, et al. (2004) Reduced competitiveness of autoanti-gen-engaged B cells due to increased dependence on BAFF. Immunity 20: 441-453. PMID: 15084273
35. Sarantopoulos S, Stevenson KE, Kim HT, Bhuiya NS, Cutler CS, et al. (2007) High levels of B-cell activating factor in patients with active chronic graft-versus-host disease. Clin Cancer Res 13: 6107-6114. PMID: 17947475
36. Sarantopoulos S, Stevenson KE, Kim HT, Cutler CS, Bhuiya NS, et al. (2009) Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. Blood 113: 3865-3874. doi: 10. 1182/blood-2008-09-177840 PMID: 19168788
37. McLean S, Di Guglielmo GM (2010) TGF beta (transforming growth factor beta) receptor type III directs clathrin-mediated endocytosis of TGF beta receptor types I and II. Biochem J 429: 137-145. doi: 10. 1042/BJ20091598 PMID: 20406198
38. Baron C, Somogyi R, Greller LD, Rineau V, Wilkinson P, et al. (2007) Prediction of graft-versus-host disease in humans by donor gene-expression profiling. PLoS Med 4: e23. PMID: 17378698
39. Lu Y, Waller EK (2009) Dichotomous role of interferon-gamma in allogeneic bone marrow transplant. Biol Blood Marrow Transplant 15: 1347-1353. doi: 10.1016/j.bbmt.2009.07.015 PMID: 19822293
40. Choi J, Ziga ED, Ritchey J, Collins L, Prior JL, et al. (2012) IFNgammaR signalingmediates alloreactive Tcell trafficking and GVHD. Blood 120: 4093-4103. doi: 10.1182/blood-2012-01-403196 PMID: 22972985
41. Koenecke C, Lee CW, Thamm K, Fohse L, Schafferus M, et al. (2012) IFN-gamma production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease. J Immunol 189: 2890-2896. doi: 10.4049/jimmunol.1200413 PMID: 22869903
42. Bryceson YT, Chiang SC, Darmanin S, Fauriat C, Schlums H, et al. (2011) Molecular mechanisms of natural killer cell activation. J Innate Immun 3: 216-226. doi: 10.1159/000325265 PMID: 21454962
43. Abrahamsen IW, Somme S, Heldal D, Egeland T, Kvale D, et al. (2005) Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease. Haematologica 90: 86-93. PMID: 15642674
44. Skert C, Damiani D, Michelutti A, Patriarca F, Arpinati M, et al. (2009) Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study. Bone Marrow Transplant 44: 729-737. doi: 10.1038/bmt.2009.80 PMID: 19398965
45. Liu Y, ZhangW(2008) Identification of a new transmembrane adaptor protein that constitutively binds Grb2 in B cells. J Leukoc Biol 84: 842-851. doi: 10.1189/jlb.0208087 PMID: 18559951
46. Choubey D (2012) Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility. Immunol Lett 147: 10-17. doi: 10.1016/j.imlet.2012.07.003 PMID: 22841963
47. Peterson KS, Huang JF, Zhu J, D'Agati V, Liu X, et al. (2004) Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest 113: 1722-1733. PMID: 15199407